rdf:type |
|
lifeskim:mentions |
umls-concept:C0030705,
umls-concept:C0040399,
umls-concept:C0087111,
umls-concept:C0681842,
umls-concept:C0684249,
umls-concept:C0871261,
umls-concept:C1274040,
umls-concept:C1704632,
umls-concept:C1706817,
umls-concept:C1709793,
umls-concept:C2911692
|
pubmed:issue |
7
|
pubmed:dateCreated |
1994-7-26
|
pubmed:abstractText |
Our hypothesis is that the concentration of 57Co-bleomycin (Co-bleo) in lung tumors reflects tumor cell kinetics and thus, prognosis. The relationship between the tumor concentration of Co-bleo measured in vivo by quantitative SPECT, response to chemotherapy and survival was investigated.
|
pubmed:commentsCorrections |
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jul
|
pubmed:issn |
0161-5505
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
35
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1129-33
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:7516965-Aged,
pubmed-meshheading:7516965-Aged, 80 and over,
pubmed-meshheading:7516965-Bleomycin,
pubmed-meshheading:7516965-Carcinoma, Non-Small-Cell Lung,
pubmed-meshheading:7516965-Carcinoma, Small Cell,
pubmed-meshheading:7516965-Cobalt Radioisotopes,
pubmed-meshheading:7516965-Female,
pubmed-meshheading:7516965-Humans,
pubmed-meshheading:7516965-Lung Neoplasms,
pubmed-meshheading:7516965-Male,
pubmed-meshheading:7516965-Middle Aged,
pubmed-meshheading:7516965-Prognosis,
pubmed-meshheading:7516965-Survival Rate,
pubmed-meshheading:7516965-Tomography, Emission-Computed, Single-Photon
|
pubmed:year |
1994
|
pubmed:articleTitle |
SPECT quantitation of cobalt-57-bleomycin to predict treatment response and outcome of patients with lung cancer.
|
pubmed:affiliation |
Department of Nuclear Medicine, Rambam Medical Center, Haifa, Israel.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|